196 related articles for article (PubMed ID: 12957325)
1. The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis.
Plutzky J
Am J Cardiol; 2003 Aug; 92(4A):34J-41J. PubMed ID: 12957325
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and additional vascular effects of thiazolidinediones.
Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
[TBL] [Abstract][Full Text] [Related]
3. [Peroxisome proliferator-activated receptors and atherosclerosis].
Jin N; Wang X
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):13-8. PubMed ID: 15127591
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
Chinetti G; Fruchart JC; Staels B
Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
[TBL] [Abstract][Full Text] [Related]
5. The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease.
Hsueh WA; Law R
Am J Cardiol; 2003 Aug; 92(4A):3J-9J. PubMed ID: 12957321
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?
Puddu P; Puddu GM; Muscari A
Int J Cardiol; 2003 Aug; 90(2-3):133-40. PubMed ID: 12957742
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors in endothelial cell biology.
Plutzky J
Curr Opin Lipidol; 2001 Oct; 12(5):511-8. PubMed ID: 11561170
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptors.
Ziouzenkova O; Perrey S; Marx N; Bacqueville D; Plutzky J
Curr Atheroscler Rep; 2002 Jan; 4(1):59-64. PubMed ID: 11772424
[TBL] [Abstract][Full Text] [Related]
9. PPAR alpha, fibrates, lipid metabolism and inflammation.
Duval C; Fruchart JC; Staels B
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041
[TBL] [Abstract][Full Text] [Related]
10. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
Moller DE; Berger JP
Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.
Pineda Torra I; Gervois P; Staels B
Curr Opin Lipidol; 1999 Apr; 10(2):151-9. PubMed ID: 10327283
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors (PPARs) in health and disease.
Ehrmann J; Vavrusová N; Collan Y; Kolár Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2002 Dec; 146(2):11-4. PubMed ID: 12572888
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator activated receptor gamma and its activation in the treatment of insulin resistance and atherosclerosis: issues and opportunities.
Beckman J; Raji A; Plutzky J
Curr Opin Cardiol; 2003 Nov; 18(6):479-85. PubMed ID: 14597889
[TBL] [Abstract][Full Text] [Related]
14. [Diabetes mellitus, inflammation and coronary atherosclerosis: current and future perspectives].
Sánchez-Recalde A ; Carlos Kaski J
Rev Esp Cardiol; 2001 Jun; 54(6):751-63. PubMed ID: 11412781
[TBL] [Abstract][Full Text] [Related]
15. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
Andrééva-Gatéva P
Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006
[TBL] [Abstract][Full Text] [Related]
16. Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
Berger J; Wagner JA
Diabetes Technol Ther; 2002; 4(2):163-74. PubMed ID: 12079620
[TBL] [Abstract][Full Text] [Related]
17. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
Evdokimova MA; Zateĭshchikov DA; Sidorenko BA
Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
19. [Thiazolidinediones and PPARgamma system in repair of liver damage].
Marra F; Pastacaldi S
Recenti Prog Med; 2002 Jan; 93(1):9-15. PubMed ID: 11851003
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptors as molecular targets for drug therapy.
Sridhar GR
J Assoc Physicians India; 2003 Jan; 51():49-52. PubMed ID: 12693455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
